Insulet Corp. cash flow to debt ratio of 54.18% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Insulet Corp.'s free cash flow has increased 23.67% from $305.40M last year to $377.70M, signaling increasing performance

Insulet Corp.'s debt to equity ratio is 0.73, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

Insulet Corp.'s debt has decreased relative to shareholder equity from 1.17 last year to 0.73 today, signaling strengthened financials

Insulet Corp. has a net debt to EBITDA ratio of 0.63x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Insulet Corp.'s interest coverage ratio of 7.30 indicates that earnings with good margin can cover interest payments on company debt

Insulet Corp.'s profit margin has decreased (-48.31%) in the last year from 20.19% to 10.44%, signaling decreasing performance

Insulet Corp.'s short-term assets of $1.89G exceed its short-term liabilities of $680.10M

Insulet Corp.'s return on assets of 10.14% is higher than the 5.00% threshold, indicating efficient asset utilization

Insulet Corp.'s return on equity of 21.38%, is higher than 15.00%, indicating good performance

Insulet Corp.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Insulet Corp. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings

Insulet Corp. has positive free cash flow, indicating the company generates cash after capital expenditures

Insulet Corp. has a free cash flow yield of 3.45%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Insulet Corp.'s yearly earnings has decreased -40.93% since last year from $418.30M to $247.10M, signaling decreasing performance

Insulet Corp.'s yearly revenue has increased 30.73% since last year from $2.07G to $2.71G, signaling increasing performance

ROIC 16.39% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Insulet Corp.'s 3-year revenue CAGR of 27.54% is positive, indicating growing revenue over the past 3 years

Insulet Corp. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

Insulet Corp. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity

Insulet Corp. has insufficient data to evaluate this check.

Insulet Corp. has an earnings yield of 2.73%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

Insulet Corp. is overvalued relative to its fair value price of 53.61 based on EBITDA multiple model

Insulet Corp. has an EV/EBITDA ratio of 19.88x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Insulet Corp. is overvalued relative to its fair value price of 115.13 based on Earnings Fair Value model

Insulet Corp. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Insulet Corp. has a price-to-book ratio of 8.50x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Insulet Corp. has a price-to-sales ratio of 3.78x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue